EP2902035

Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    14.10.2011
  • :
    20.6.2018
  • :
    14004427.2
  • :
    13.10.2031
  • :
    Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.

14.10.2011
20.6.2018
  • :
    Xigen Inflammation Ltd.
  • :
    Arch. Makariou III 195 Neocleous House, 3030, Limassol, CY
  • :
    Combette, Jean-Marc
  • :
    Saint Cergues, FR
  • :
    Deloche, Catherine
  • :
    Genf, CH
  • :
    Abadie, Claire
  • :
    Annecy, FR
  • :
    PCT/EP2010/006284
  • :
    14.10.2010
  • :
    WO
  • :
    PCT/EP2011/000307
  • :
    25.1.2011
  • :
    WO
  • :
    A61K 38/00, A61K 38/03, A61K 38/04, A61P 27/02